Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy

MILAN & SAN MATEO, Calif.--(BUSINESS WIRE)--Dompé advances a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) for spastic cerebral palsy (CP).